XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Series A Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Total
Beginning balance, shares (in thousands) at Dec. 31, 2018 0 1,396 141,041      
Beginning balance, amount at Dec. 31, 2018 $ 0 $ 1 $ 141 $ 0 $ 649 $ 791
Effect of reverse merger, shares (in thousands)     2,377,530      
Effect of reverse merger, amount     $ 2,378 (2,378)   0
Conversion of Series A/B convertible preferred stock, shares (in thousands)   (1,396) 13,963,048      
Conversion of Series A convertible preferred stock, amount   $ (1) $ 13,963 (13,962)   0
Issuance of common stock and warrants in a private offering, net of $7,762 warrant liability, shares (in thousands) 206   1,551,466      
Issuance of common stock and warrants in a private offering, net of $7,762 warrant liability, amount $ 0   $ 1,551 18,186   19,737
Offering cost related to private offering       (4,339)   (4,339)
Reclassification of liability awards to equity           0
Accrued dividends payable on Series A convertible preferred stock           0
Cash distributions to CCD Members       (17,430) (979) (18,409)
Stock compensation, shares (in thousands)     902,662      
Stock compensation, amount     $ 903 2,456   3,359
Net loss         999 999
Ending balance, shares (in thousands) at Sep. 30, 2019 206 0 18,935,747      
Ending balance, amount at Sep. 30, 2019 $ 0 $ 0 $ 18,936 (17,467) 669 2,138
Beginning balance, shares (in thousands) at Jun. 30, 2019 206 0 18,935,747      
Beginning balance, amount at Jun. 30, 2019 $ 0 $ 0 $ 18,936 (17,749) 669 299
Stock compensation, amount       282   282
Net loss         1,557 1,557
Ending balance, shares (in thousands) at Sep. 30, 2019 206 0 18,935,747      
Ending balance, amount at Sep. 30, 2019 $ 0 $ 0 $ 18,936 (17,467) 669 2,138
Beginning balance, shares (in thousands) at Dec. 31, 2019 204 0 18,973,828      
Beginning balance, amount at Dec. 31, 2019 $ 0 $ 0 $ 18,974 (17,045) (2,476) (547)
Conversion of Series A/B convertible preferred stock, shares (in thousands)     16,925      
Conversion of Series A convertible preferred stock, amount     $ 17 (17)   0
Reclassification of liability awards to equity       1,638   1,638
Accrued dividends payable on Series A convertible preferred stock       (1,650)   (1,650)
Net loss         (11,384) (11,384)
Ending balance, shares (in thousands) at Sep. 30, 2020 204 0 18,990,753      
Ending balance, amount at Sep. 30, 2020 $ 0 $ 0 $ 18,991 (15,679) (13,860) (10,548)
Beginning balance, shares (in thousands) at Jun. 30, 2020 204 0 18,990,753      
Beginning balance, amount at Jun. 30, 2020 $ 0 $ 0 $ 18,991 (16,060) (7,036) (4,105)
Stock compensation, amount       381   381
Net loss         (6,824) (6,824)
Ending balance, shares (in thousands) at Sep. 30, 2020 204 0 18,990,753      
Ending balance, amount at Sep. 30, 2020 $ 0 $ 0 $ 18,991 $ (15,679) $ (13,860) $ (10,548)